Ambalal Sarabhai Enterprises Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Ambalal Sarabhai Enterprises announced that the Annual General Meeting(AGM) of the company will be held on 30 July 2026.

Net profit of Ambalal Sarabhai Enterprises reported to Rs 6.50 crore in the quarter ended March 2026 as against net loss of Rs 0.27 crore during the previous quarter ended March 2025. Sales rose 1.05% to Rs 65.49 crore in the quarter ended March 2026 as against Rs 64.81 crore during the previous quarter ended March 2025.

For the full year,net profit rose 261.05% to Rs 17.80 crore in the year ended March 2026 as against Rs 4.93 crore during the previous year ended March 2025. Sales rose 3.10% to Rs 202.27 crore in the year ended March 2026 as against Rs 196.19 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Net profit of Ambalal Sarabhai Enterprises rose 63.23% to Rs 3.64 crore in the quarter ended December 2025 as against Rs 2.23 crore during the previous quarter ended December 2024. Sales rose 13.12% to Rs 52.00 crore in the quarter ended December 2025 as against Rs 45.97 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News